SEC Form 4 · accession 0001209191-17-026571
INCYTE CORP · INCY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven H Stein
Officer — EVP & Chief Medical Officer
Period of report
Apr 7, 2017
Accepted (ET)
Apr 11, 2017 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 7, 2017 | M | 27,000 | $88.68 | A | 41,648 | D | |
| Common Stock | Apr 7, 2017 | M | 5,000 | $95.76 | A | 46,648 | D | |
| Common StockF1,F2,F3 | Apr 7, 2017 | S | 27,000 | $137.88 | D | 19,648 | D | |
| Common StockF2,F3,F4 | Apr 7, 2017 | S | 5,000 | $137.91 | D | 14,648 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F5 | $88.68 | Apr 7, 2017 | M | 27,000 | D | — | Mar 1, 2022 | Common Stock | 27,000 | 15,891 | D |
| Non-Qualified Stock Option (right to buy)F6 | $95.76 | Apr 7, 2017 | M | 5,000 | D | — | Jan 6, 2023 | Common Stock | 5,000 | 13,262 | D |
Explanation of responses
- F1Represents weighted average sale price. Actual sale prices ranged from $136.55 - $139.74.
- F2Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
- F3This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- F4Represents weighted average sale price. Actual sale prices ranged from $136.61 - $139.85.
- F5Beginning March 2, 2015, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- F6Beginning January 7, 2016, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years